Ascendis Pharma A/S (NASDAQ:ASND) Q2 2024 Earnings Call Transcript September 3, 2024
Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-2.05 EPS, expectations were $-1.54.
Operator: Hello. Thank you for standing by. Welcome to Ascendis Pharma’s Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator instructions] I would now like to turn...
